Hopes rise for patients with drug resistant HIV

BMJ 2002; 325 doi: (Published 13 July 2002) Cite this as: BMJ 2002;325:62
  1. Alex Vass
  1. BMJ

    New treatments may soon be available for patients with HIV which has become resistant to existing treatments.

    The results are from completed phase III trials of a new category of anti-HIV drug called “fusion inhibitors.” The results show that twice as many patients using the first fusion inhibitor, T-20, in combination with antiretroviral drugs, achieved reductions in their viral load to below detectable levels, compared with patients taking antiretroviral drugs alone.

    Significant improvements in immune cell (CD4) counts …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription